Answer
Briviact (brivaracetam) is licensed from 2 years of age as add-on treatment for partial-onset seizures with or without secondary generalisation in people with epilepsy.
Sources for this answer
- Briviact 10 mg film-coated tabletsUCB Pharma Limited · emc · SmPC §4.1 Therapeutic Indications · Version 18Document updated
Sources checked